Cowen analyst Doug Schenkel initiates coverage on Singular Genomics (NASDAQ: OMIC) with a Outperform rating.The analyst comments "Singular is a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE